Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (181-190 of 333) with videos related to

Pageof 34
Sort By:
Progress in Clinical and Biological Research|January 1, 1986
Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasisG E Gallick, P G Sacks, S A Maxwell, et al.
Blood|April 15, 1990
Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromesS Vadhan-Raj, W N Hittelman, J L Lepe-Zuniga, et al.
American Journal of Clinical Oncology|April 1, 1993
The myeloprotective effect of recombinant human granulocyte-macrophage colony-stimulating factor given sequentially with continuous infusion vinblastine in metastatic breast cancer patientsR L Theriault, G Fraschini, F A Holmes, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Preclinical and clinical effects of the hematopoietic colony stimulating factorsH E Broxmeyer, S Vadhan-Raj, G Hangoc, et al.
Investigational New Drugs|February 1, 1991
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinumK Dhingra, M Talpaz, H M Dhingra, et al.
Cancer|April 1, 1990
Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administrationA A Zukiwski, C L David, J Coan, et al.
Annals of the New York Academy of Sciences|January 1, 1989
In vivo biologic activities of recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W N Hittelman, H E Broxmeyer, et al.
Cancer Treatment Reports|July 1, 1978
Combination chemoimmunotherapy for extensive non-oat cell lung cancerB F Issell, M Valdivieso, E M Hersh, et al.
Blood|October 1, 1987
Therapy of chronic myelogenous leukemia with recombinant interferon-gammaR Kurzrock, M Talpaz, H Kantarjian, et al.
Cancer Treatment Reports|February 1, 1976
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanomaJ U Gutterman, G M Mavligit, R Reed, et al.
Pageof 34

Showing results (181-190 of 333) with videos related to

Sort By:
Pageof 34
Progress in Clinical and Biological Research|January 1, 1986
Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasisG E Gallick, P G Sacks, S A Maxwell, et al.
Blood|April 15, 1990
Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromesS Vadhan-Raj, W N Hittelman, J L Lepe-Zuniga, et al.
American Journal of Clinical Oncology|April 1, 1993
The myeloprotective effect of recombinant human granulocyte-macrophage colony-stimulating factor given sequentially with continuous infusion vinblastine in metastatic breast cancer patientsR L Theriault, G Fraschini, F A Holmes, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Preclinical and clinical effects of the hematopoietic colony stimulating factorsH E Broxmeyer, S Vadhan-Raj, G Hangoc, et al.
Investigational New Drugs|February 1, 1991
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinumK Dhingra, M Talpaz, H M Dhingra, et al.
Cancer|April 1, 1990
Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administrationA A Zukiwski, C L David, J Coan, et al.
Annals of the New York Academy of Sciences|January 1, 1989
In vivo biologic activities of recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W N Hittelman, H E Broxmeyer, et al.
Cancer Treatment Reports|July 1, 1978
Combination chemoimmunotherapy for extensive non-oat cell lung cancerB F Issell, M Valdivieso, E M Hersh, et al.
Blood|October 1, 1987
Therapy of chronic myelogenous leukemia with recombinant interferon-gammaR Kurzrock, M Talpaz, H Kantarjian, et al.
Cancer Treatment Reports|February 1, 1976
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanomaJ U Gutterman, G M Mavligit, R Reed, et al.
Pageof 34